Positron Corporation (POSC)
OTCMKTS · Delayed Price · Currency is USD
1.440
-0.040 (-2.70%)
Jul 17, 2025, 11:07 AM EDT
Positron Revenue
Positron had revenue of $304.00K in the quarter ending September 30, 2015, a decrease of -23.23%. This brings the company's revenue in the last twelve months to $1.24M, down -26.50% year-over-year. In the year 2014, Positron had annual revenue of $1.47M, down -10.06%.
Revenue (ttm)
1.24M
Revenue Growth
-26.50%
P/S Ratio
37.57
Revenue / Employee
65.11K
Employees
19
Market Cap
46.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 1.47M | -164.00K | -10.06% |
| Dec 31, 2013 | 1.63M | -1.17M | -41.81% |
| Dec 31, 2012 | 2.80M | -3.86M | -57.96% |
| Dec 31, 2011 | 6.66M | 2.04M | 44.13% |
| Dec 31, 2010 | 4.62M | 3.18M | 219.71% |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
| Dec 31, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |
Positron News
- 7 weeks ago - Positron Corporation Expands Market Presence with Sale of NeuSight PET-CT Scanner - GlobeNewsWire
- 3 months ago - Positron Corporation Secures Agreement to Sell Four PET-CT Scanners - GlobeNewsWire
- 3 months ago - Positron Corporation Secures $8 Million in Capital to Accelerate Growth and Market Expansion - GlobeNewsWire
- 5 months ago - Positron Corporation Secures Agreement for Three NeuSight PET-CT 64 Slice Scanners - GlobeNewsWire
- 6 months ago - Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners - GlobeNewsWire
- 6 months ago - Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners - GlobeNewsWire
- 6 months ago - Actineer Appoints Radiopharmaceutical Executive Joseph Oliverio as President and CEO - Business Wire
- 6 months ago - Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach - GlobeNewsWire